The Global Fund and the Three Diseases
The Global Fund to Fight AIDS, Tuberculosis and Malaria is the world’s largest public health financier, supporting programs in more than 140 countries. It provides more than 20 percent of international funding for HIV/AIDS; more than 70 percent of international funding for tuberculosis; and more than 40 percent of international funding for malaria.
The Global Fund has signed more than $36 billion in grant funding to date. These financial resources are provided to in-country partners in support of programs that have:
- Provided antiretroviral treatment for 9.2 million people;
- Provided 3.6 million HIV-positive pregnant women with ARV prophylaxis to prevent mother-to-child transmission;
- Provided 7.8 million basic care and support services provided to orphans and other vulnerable children;
- Provided 509 million HIV testing and counseling sessions;
- Treated 15.1 million cases of tuberculosis;
- Treated 267,000 people for MDR-TB;
- Distributed 659 million insecticide-treated nets; and
- Treated 582 million cases of malaria.
What Makes the Global Fund Unique?
Transparency, accountability and partnership form the foundation on which the Global Fund was established, and they remain the key pillars to successful implementation of programs that save and improve lives. The Global Fund is nearly unparalleled in its dedication to transparency and accountability.
As an independent, multilateral financing mechanism, the Global Fund does not implement the programs to which it provides grants. Instead, partners from government, civil society, the private sector and communities affected by the diseases help Global Fund grant recipients with the management and technical expertise needed to achieve results.
The Global Fund and U.S. Bilateral Programs
Partnerships have been integral to the Global Fund’s successful model since its founding. Through unique partnerships among governments, civil society, faith groups, the private sector and affected communities, the Global Fund has saved millions of lives to date.
Chief among these partnerships are U.S. global health initiatives. Close coordination on the ground between the multilateral Global Fund and U.S. bilateral programs — such as the President’s Emergency Plan for AIDS Relief (PEPFAR), the President’s Malaria Initiative (PMI) and the U.S. Agency for International Development’s (USAID) Tuberculosis Program — is vital to the success of global health programs around the world.
The Global Fund and PEPFAR are the leading global financiers of the fight against HIV and AIDS. In fact, the two jointly finance approximately 80 percent of the national HIV programs in countries with the highest burden and lowest resources.
Together, the Global Fund and USAID work to identify gaps in national tuberculosis strategies and, by coordinating resources and activities, help to fill them.
Additionally, the Global Fund works with PMI to help end the burden of malaria. In all of the 19 countries where PMI works, significant malaria financing has been received from the Global Fund. Coordination between the two programs is ongoing and critical to their success.